Vaginal prolapse is a painful condition generally experienced by women who have undergone a hysterectomy. To surgically repair this condition, surgeons implant a mesh patch to the pelvic floor, reinforcing the vaginal wall.
C.F. Bard, the manufacturer of Avaulta, got approval in 2008 from the FDA for a 501(k) application allowing them to fast-track their mesh patch for approval without the proper standard testing that these kinds of products need. As a result, patients reported severe injuries and symptoms related to the procedure, raising questions about the safety of this implant.
Some of the reported complications of Bard Avaulta patches include:
The manufacturers of this product are quick to place blame on the surgeons who performed the procedure, but the experienced mesh lawsuit lawyers at Goldblatt + Singer will fight to get you compensation for the injuries caused by Bard Avaulta Patch surgeries.
If you or someone you love is suffering from vaginal prolapse as a result of a Bard Avaulta Patch surgery, contact Goldblatt + Singer today for a risk-free consultation. We’ve recovered over $400 million for injured people since 1949.